Trials / Completed
CompletedNCT02538874
A Study of BMS-986171 in Healthy People to Assess Safety, to Measure Blood Levels of Drug, and to Find Out What the Drug Does to the Body
A Randomized, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986171 in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 275 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 21 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess safety, to measure blood levels of drug, and to find out what the drug does to the body.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BMS-986171 | |
| OTHER | Placebo |
Timeline
- Start date
- 2015-10-31
- Primary completion
- 2016-11-04
- Completion
- 2016-11-05
- First posted
- 2015-09-02
- Last updated
- 2017-05-24
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT02538874. Inclusion in this directory is not an endorsement.